Back to search

Institutional Repository of Vilnius University

Non-Invasive biomarkers for early diagnosis and prognosis of cholangiocarcinoma /

Abstract

dc:description

Cholangiocarcinoma, also known as CCA, is a malignant tumour affecting the hepatobiliary system. Biliary cancer evolved over time to the second most commonly encountered type of liver cancer globally. Regardless diagnosis’ improvements and management that surfaced in the previous years, one can say that the sensitivity as well as the specificity of the existing diagnostic tools are still lacking, and the prognosis of the patients has not substantially ameliorated. Moreover, in the last 20 years the global mortality rates have been increasing, placing CCA as a worldwide uprising health problem. The mainstay potentially curative therapy is surgical resection with or without adjuvant therapy, yet most patients with CCA do not present at an early, but at an advanced stage, where those regimens show less efficacy than they do in earlier phases of this malignant disease. Chemotherapy is a mainstay treatment for advanced-stage CCA and the role of targeted therapy for those patients is currently being studied extensively. A potential solution to this problem could be the utilization of biomarkers that are able to detect CCA at an earlier time than nowadays used tests are able to. Considering the potential of DNA methylation or the use of the N-Nose test to diagnose cholangiocarcinoma according to its chemotaxis, opens up many different approaches on how to diagnose CCA. Through the use of specific biomarkers, one could be able to identify certain gene mutations that might result in malignant growth, leading to a possible earlier diagnosis and a consequent efficient treatment before cancer develops further. Furthermore, those biomarkers proved to be efficient in other malignant diseases as well, but since these markers are a rather new discovery, their exact mechanism and potential in the clinical setting must be further understood. Therefore, biomarker discovery and a better understanding of its potential for chemotherapy are pivotal to improving patients’ welfare and outcome.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Beselt, Christian,

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
eng

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Beselt, Christian,. Non-Invasive biomarkers for early diagnosis and prognosis of cholangiocarcinoma /. Institutional Repository of Vilnius University, 2023. https://repository.vu.lt/VU:ELABAETD192827242&prefLang=en_US